Clinical trial

Pentoxifylline as Anti-Inflammatory in Patients With Rheumatoid Arthritis

NCT06998628

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-06-02

PhasePHASE2

Study timeline

Study start (actual)2025-06-02Date precision: day

Registry last updated2026-10-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

MethotrexateDRUG · verified · RxNorm: methotrexate

PentoxifyllineDRUG · verified · RxNorm: pentoxifylline

Sponsors & collaborators

Tanta Universitylead sponsor

Dr. Mustafa Adel Mustafa Elmenawy Lecturer of Rheumatology and Rehabilitation, Faculty of Medicine - El-Azhar University - Damiettacollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06998628 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.